Unraveling the anticancer effect of curcumin and resveratrol
AR Pavan, GDB Silva, DH Jornada, DE Chiba… - Nutrients, 2016 - mdpi.com
Resveratrol and curcumin are natural products with important therapeutic properties useful
to treat several human diseases, including cancer. In the last years, the number of studies …
to treat several human diseases, including cancer. In the last years, the number of studies …
Structure, expression and functions of MTA genes
R Kumar, RA Wang - Gene, 2016 - Elsevier
Metastatic associated proteins (MTA) are integrators of upstream regulatory signals with the
ability to act as master coregulators for modifying gene transcriptional activity. The MTA …
ability to act as master coregulators for modifying gene transcriptional activity. The MTA …
Methylation landscape of human breast cancer cells in response to dietary compound resveratrol
Aberrant DNA methylation is a frequent epigenetic alteration in cancer cells that has
emerged as a pivotal mechanism for tumorigenesis. Accordingly, novel therapies targeting …
emerged as a pivotal mechanism for tumorigenesis. Accordingly, novel therapies targeting …
[HTML][HTML] Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer
Overexpression of the epigenetic modifier metastasis-associated protein 1 (MTA1) is
associated with aggressive human prostate cancer. The purpose of this study was to …
associated with aggressive human prostate cancer. The purpose of this study was to …
Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced …
Background Signal transducers and activators of transcription (STAT) proteins are critical
transcription factor that are aberrantly activated in various types of malignancies, including …
transcription factor that are aberrantly activated in various types of malignancies, including …
Resveratrol prevents retinal dysfunction by regulating glutamate transporters, glutamine synthetase expression and activity in diabetic retina
K Zeng, N Yang, D Wang, S Li, J Ming, J Wang… - Neurochemical …, 2016 - Springer
This study investigated the effects of resveratrol (RSV) on retinal functions, glutamate
transporters (GLAST) and glutamine synthetase (GS) expression in diabetic rats retina, and …
transporters (GLAST) and glutamine synthetase (GS) expression in diabetic rats retina, and …
Food-based natural products for cancer management: Is the whole greater than the sum of the parts?
SS Hussain, AP Kumar, R Ghosh - Seminars in cancer biology, 2016 - Elsevier
The rise in cancer incidence and mortality in developing countries together with the human
and financial cost of current cancer therapy mandates a closer look at alternative ways to …
and financial cost of current cancer therapy mandates a closer look at alternative ways to …
Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers
A Yuqing Yang, H Kim, W Li… - Current topics in …, 2016 - ingentaconnect.com
Post-translational modifications can affect gene expression in a long-term manner without
changes in the primary nucleotide sequence of the DNA. These epigenetic alterations …
changes in the primary nucleotide sequence of the DNA. These epigenetic alterations …
Natural epigenetic-modifying molecules in medical therapy
A Kumar, NA Butt, AS Levenson - Medical epigenetics, 2016 - Elsevier
In the last decade, strong evidence has emerged on the link between diet and epigenetic
mechanisms of diseases. Dietary bioactive molecules from vegetables, fruits, and some …
mechanisms of diseases. Dietary bioactive molecules from vegetables, fruits, and some …
Resveratrol overcomes cellular resistance to vemurafenib through dephosphorylation of akt in BRAF-mutated melanoma cells
H Luo, M Umebayashi, K Doi, T Morisaki… - Anticancer …, 2016 - ar.iiarjournals.org
Background/Aim: The serine/threonine-protein kinase B-Raf (BRAF) V600E mutant
(BRAFV600E) inhibitor vemurafenib, has improved clinical outcomes for patients with …
(BRAFV600E) inhibitor vemurafenib, has improved clinical outcomes for patients with …